Hhdpharm 99% API Brigatinib Ap26113 CAS 1197958-12-5 for Targeted Cancer Therapy

Model NO.
CAS 1197958-12-5
Shelf Life
2 Years
Model No
Hhd
Grade
Pharmaceutical Grade
Color
White
Transport Package
Alumininum Foli Bags
Specification
10g, 50g, 200g, 1kg, 5kg
Trademark
hhdpharm
Origin
China
Reference Price
Please contact us for quote
Contact Us

Product Description

Hhdpharm 99% API Brigatinib Ap26113 CAS 1197958-12-5 for Targeted Cancer Therapy
Product Name: AP26113
Synonyms: 5-chloro-2-N-[4-[4-(dimethylamino)piperidin-1-yl]-2-methoxyphenyl]-4-N-(2-dimethylphosphorylphenyl)pyrimidine-2,4-diamine;AP26113-ANALOG;(2-((5-Chloro-2-((4-(4-(dimethylamino)piperidin-1-yl)-2-methoxyphenyl)amino)pyrimidin-4-yl)ami;AP26113;AP26113/AP-26113;5-chloro-N2-(4-(4-(diMethylaMino)piperidin-1-yl)-2-Methoxy-5-Methylphenyl)-N4-(2-(diMethylphosphoryl)phenyl)pyriMidine-2,4-diaMine;5-Chloro-N2-[4-[4-(dimethylamino)-1-piperidinyl]-2-methoxyphenyl]-N4-[2-(dimethylphosphinyl)phenyl]-2,4-pyrimidinediamine;5-Chloro-N2-[4-[4-(diMethylaMino)-1-piperidinyl]-2-Methoxyphenyl]-N4-[2-(diMethylphosphinyl)phenyl]
CAS: 1197958-12-5
MF: C27H36ClN6O4P
MW: 575.039301
Boiling point: 737.6±70.0 °C
Density: 1.29±0.1 g/cm3

Hhdpharm 99% API Brigatinib Ap26113 CAS 1197958-12-5 for Targeted Cancer Therapy

AP26113 (also known as Brigatinib) is an investigated small molecule for targeted cancer therapy. It is a potent dual inhibitor of anaplastic lymphoma kinase (ALK) and epidermal factor receptor (EGFR). It is mainly under investigation for its treatmentefficacy on non-small cell lung cancer (NSCLC) where ALK is activated and EGFP mutations frequently occur.  

Hhdpharm 99% API Brigatinib Ap26113 CAS 1197958-12-5 for Targeted Cancer Therapy
Hhdpharm 99% API Brigatinib Ap26113 CAS 1197958-12-5 for Targeted Cancer Therapy
Hhdpharm 99% API Brigatinib Ap26113 CAS 1197958-12-5 for Targeted Cancer Therapy
Hhdpharm 99% API Brigatinib Ap26113 CAS 1197958-12-5 for Targeted Cancer Therapy
Hhdpharm 99% API Brigatinib Ap26113 CAS 1197958-12-5 for Targeted Cancer Therapy

Hhdpharm 99% API Brigatinib Ap26113 CAS 1197958-12-5 for Targeted Cancer Therapy
Hhdpharm 99% API Brigatinib Ap26113 CAS 1197958-12-5 for Targeted Cancer Therapy

Hhdpharm 99% API Brigatinib Ap26113 CAS 1197958-12-5 for Targeted Cancer Therapy
Hhdpharm 99% API Brigatinib Ap26113 CAS 1197958-12-5 for Targeted Cancer Therapy

Hhdpharm 99% API Brigatinib Ap26113 CAS 1197958-12-5 for Targeted Cancer Therapy
Hhdpharm 99% API Brigatinib Ap26113 CAS 1197958-12-5 for Targeted Cancer Therapy

Hhdpharm 99% API Brigatinib Ap26113 CAS 1197958-12-5 for Targeted Cancer Therapy
Hhdpharm 99% API Brigatinib Ap26113 CAS 1197958-12-5 for Targeted Cancer Therapy

Q1: What's your MOQ?
A: It depends on different products,we can accept sample order or provide free sample for your test.

Q2:How about delivery leadtime?
A:Delivery lead time: About 3-5 days after payment confirmed. (Chinese holiday not included)

Q3: Is there a discount?
A:Different quantity has different discount.

Q4:How to start orders or make payments?
A:Proforma invoice will be sent first after confirmation of order, enclosed our bank information. Payment by T/T, Western Union or Bitcoin.

Q5: How do you treat quality complaint?
A:First of all, our quality control will reduce the quality problem to near zero. If there is a real quality problem caused by us, we will send you free goods for replacement or refund your loss.

Q6. We don't know you at all, how can we trust you?


Q7.Do you test all your goods before delivery?
A:Yes, we have 100% test before delivery,International Authorized Third-Party Test for the products if you need are highly welcomed.

 

Pharmaceutical Intermediate

MAZAD.TODAY, 2023